XML 41 R27.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Option Plan (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
Stock option activity under the Company's 2019 Plan is set forth below:
 
Number of
Options
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding, December 31, 2020
1,975,761 $11.81 8.71$6,750 
Granted229,850 $16.79 
Exercised(11,950)$7.40 
Forfeited(128,665)$14.44 
Expired(50,666)$17.18 
Outstanding, December 31, 2021
2,014,330 $12.10 7.87$5,428 
Vested and expected to vest, December 31, 2021
2,014,330 $12.10 7.87$5,428 
Options exercisable, December 31, 2021
1,050,036 $10.17 7.53$4,262 
Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity
Restricted stock unit activity under the Company's 2019 Plan is set forth below:
Number of
Shares
Weighted-
Average
Grant Date Fair Value
Aggregate
Intrinsic
Value
Outstanding, December 31, 2020
— $— $— 
Awards granted449,000 $16.51 
Awards released— $— 
Awards canceled(33,675)$16.24 
Outstanding, December 31, 2021
415,325 $16.54 $4,830 
Schedule of Fair Value Assumptions, Stock Options
The fair value of employee stock options was estimated using the following assumptions to determine the fair value of stock options granted:
 
 Years Ended December 31,
 20212020
Expected volatility
56%-60%
47%-53%
Risk-free interest rate
0.8%-1.1%
0.4%-1.7%
Dividend yield
Expected term (in years)
5.50-6.08
5.5-6.08
The following assumptions were used to calculate the stock-based compensation for each stock purchase right granted under the ESPP:
 
 Years Ended December 31,
 20212020
Expected volatility
45%-60%
58.0%-83.0%
Risk-free interest rate
0.1%
0.1%-1.1%
Dividend yield
Expected term (in years)0.50.5
Stock-based compensation expense related to the ESPP for the years ended December 31, 2021 and 2020 was $0.2 million and less than $0.1 million, respectively. As of December 31, 2021, total unrecognized compensation cost related to stock purchase rights granted under the ESPP was less than $0.1 million, which is expected to be recognized over a remaining weighted-average vesting period of 0.2 years.
Schedule of Non-cash Stock-based Compensation Expense
Total non-cash stock-based compensation expense recorded related to options granted, restricted stock units granted and stock purchase rights granted under the ESPP in the statement of operations is as follows (in thousands):
 
 Years Ended December 31,
 20212020
Cost of revenue$164 $33 
Selling, general and administrative3,943 2,419 
Research and development621 242 
Total$4,728 $2,694 
Schedule of Common Stock Reserved For Future Issuance
Common stock reserved for future issuance consists of the following at December 31, 2021:
Warrants to purchase common stock1,214,059 
Common stock option grants issued and outstanding2,014,330 
Common stock reserved for issuance upon vesting of outstanding restricted stock units415,325 
Common shares available for grant under the 2019 Plan1,179,571 
Common shares available for future issuance under ESPP327,516 
Total5,150,801